CD8A and ovarian cancer: However, despite the high proportion of HRD ovarian cancers with suspected high tumor mutational burden (TMB), increased infiltration by CD8+ tumor-infiltrating lymphocytes (TILs), and high expression of tumor antigens capable of eliciting spontaneous anti-tumor responses, initial attempts using immunotherapy in ovarian cancer were largely disappointing [111].